OPKO Health, Inc. (NASDAQ:OPK) has a beta value of 2.24 and has seen 7,870,833 shares traded in the recent trading session. The company, currently valued at $2.16 Billion, closed the recent trade at $3.28 per share which meant it gained $0.2 on the day or 9.49% during that session. The OPK stock price is 1.22% off its 52-week high price of $3.24 and 65.85% above the 52-week low of $1.12. If we look at the company’s 10-day average daily trading volume, we find that it stood at 11.94 Million shares traded. The 3-month trading volume is 13.27 Million shares.
OPKO Health, Inc. (NASDAQ:OPK) trade information
Sporting 8.64% in the green today, the stock has traded in the green over the last five days, with the highest price hit on Tuesday, Jun 30 when the OPK stock price touched $3.19-2 or saw a rise of 2.04%. Year-to-date, OPKO Health, Inc. shares have moved 112.59%, while the 5-day performance has seen it change 18.82%. Over the past 30 days, the shares of OPKO Health, Inc. (NASDAQ:OPK) have changed 37.06%. Short interest in the company has seen 117Million shares shorted with days to cover at 8.82.
OPKO Health, Inc. (OPK) estimates and forecasts
Figures show that OPKO Health, Inc. shares have underperformed across the wider relevant industry. The company’s shares have gained +96.67% over the past 6 months, with this year growth rate of -26.83%, compared to 2.5% for the industry. Other than that, the company has, however, increased its growth outlook for the 2020 fiscal year revenue. Growth estimates for the current quarter are 20% and 27.3% for the next quarter. Revenue growth from the last financial year stood is estimated to be +0.4%.
5 analysts offering their estimates for the company have set an average revenue estimate of $223.14 Million for the current quarter. 5 have an estimated revenue figure of $233.16 Million for the next quarter concluding in September 01, 2020. Year-ago sales stood $226.37 Million and $228.77 Million respectively for this quarter and the next, and analysts expect sales will grow by -1.4% for the current quarter and 1.9% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -5.4% over the past 5 years. Earnings growth for 2020 is a modest -94.6% while over the next 5 years, the company’s earnings are expected to increase by 12%.
OPKO Health, Inc. (NASDAQ:OPK)’s Major holders
Insiders own 39.85% of the company shares, while shares held by institutions stand at 26.36% with a share float percentage of 43.82%. Investors are also buoyed by the number of investors in a company, with OPKO Health, Inc. having a total of 251 institutions that hold shares in the company. The top two institutional holders are Vanguard Group, Inc. (The) with over 37.37 Million shares worth more than $50.08 Million. As of March 30, 2020, Vanguard Group, Inc. (The) held 5.58% of shares outstanding.
The other major institutional holder is Blackrock Inc., with the holding of over 35.45 Million shares as of March 30, 2020. The firm’s total holdings are worth over $47.5 Million and represent 5.29% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Vanguard Small-Cap Index Fund. As of March 30, 2020, the former fund manager holds about 1.75% shares in the company for having 11708832 shares of worth $15.69 Million while later fund manager owns 10.35 Million shares of worth $13.87 Million as of March 30, 2020, which makes it owner of about 1.54% of company’s outstanding stock.